skip to Main Content

Pioneering The Next Generation of Solid Tumor T Cell Immunotherapies

Who We Are

Focusing on improving the lives of patients with solid tumor cancers.

Our Science

Developing the most mature bispecific T cell engaging platform in its class.


Advancing our COBRA™ pipeline toward the clinic.

Back To Top